Clinical experience with an aminoglycoside antibiotic, dibekacin, in the treatment of infectious diseases in obstetric and gynecological field .
D000328:Adult; D000617:Aminoglycosides / Q000009:adverse effects; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D001424:Bacterial Infections / Q000188:drug therapy*; D003982:Dibekacin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D004341:Drug Evaluation; D004716:Endometritis / Q000188:drug therapy / Q000382:microbiology; D005260:Female; D005831:Genital Diseases, Female / Q000188:drug therapy*; D006801:Humans; D007612:Kanamycin / Q000031:analogs & derivatives*; D008875:Middle Aged; D000292:Pelvic Inflammatory Disease / Q000188:drug therapy / Q000382:microbiology; D010538:Peritonitis / Q000188:drug therapy; D011247:Pregnancy; D011645:Puerperal Infection / Q000188:drug therapy; D011704:Pyelonephritis / Q000188:drug therapy / Q000382:microbiology; D012488:Salpingitis / Q000188:drug therapy
D000617:Aminoglycosides; D000900:Anti-Bacterial Agents; D003982:Dibekacin; D007612:Kanamycin